BioSpace News Archive

Senseonics Holdings, Inc. announced that it had made equity grants to new employees under its 2019 Inducement Plan in accordance with NYSE American Company Guide Section 711.

Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2019 fourth quarter financial results after the close of the market on Thursday, February 6th

Flexion Therapeutics, Inc. announced equity inducement grants to five new employees consisting of an aggregate of 17,000 stock options and 2,800 restricted stock units.

Sage Therapeutics, Inc. announced that on Thursday, January 2, 2020, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 11,850 shares of its common stock, and 1,975 performance restricted stock units to four new employees under Sage’s 2016 Inducement Equity Plan.

Health Canada is advising Canadians that it seized two unauthorized ZO Medical skin-whitening creams from Toronto Dermatology Centre in North York, Ontario, because they may pose serious health risks, such as blisters, scarring, skin discolouration and possibly cancer.

Organigram Holdings Inc. announced it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close.

RadioMedix Inc. is pleased to announce that the company has been selected for the 2019-2020 Commercialization Accelerator Program by the National Institute of Health SBIR/STTR program office.

Atrium Innovations, a Nestlé Health Science company, to leverage clinician-designed, algorithm-driven platform with healthcare providers